Laurus Labs

Market Cap

28,939.38 Cr

EPS

2.98

PE Ratio

147.29

Dividend Yield

0.15 %

Industry

Healthcare

52 Week High

646.20

52 Week low

373.10

PB Ratio

7.13

Debt to Equity

0.56

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Analyst Rating

- By Refinitiv from11 analysts

Analysts have suggested that investors can sell this stock

Buy36.36 %

36.36 %

Hold9.09 %

9.09 %

Sell54.55 %

54.55 %

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,669.30	4,00,520.99	34.13	49,887.20	12.06	9,648	13.77	37.74
Divis Laboratories	5,978.30	1,58,705.08	76.14	8,184.00	0.89	1,600	64.53	51.57
Cipla	1,479.70	1,19,502.65	23.70	26,520.70	14.17	4,155	47.38	51.15
Torrent Pharmaceuticals	3,095.95	1,04,781.02	56.64	10,785.70	11.59	1,656	13.54	45.77
Dr Reddys Laboratories	1,170.95	97,705.34	18.09	28,905.40	12.36	5,578	1.69	30.83
Mankind Pharma	2,348.45	96,889.27	47.77	10,615.60	19.57	1,942	-16.38	39.42
Zydus Life Science	899.65	90,525.84	19.78	19,831.50	13.82	3,831	29.92	36.77
Lupin	1,977.50	90,213.07	31.46	20,141.50	19.94	1,936	38.82	38.83
Aurobindo Pharma	1,121.25	65,122.38	18.72	29,559.20	17.55	3,169	-10.04	42.81
Abbott	29,429.65	62,535.95	47.37	6,097.20	10.80	1,201	16.01	61.56

Growth Rate

Revenue Growth

-16.20 %

Net Income Growth

-78.89 %

Cash Flow Change

-33.02 %

ROE

-79.22 %

ROCE

-67.38 %

EBITDA Margin (Avg.)

-39.99 %

Quarterly Financial Results

Quarterly Financials	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	412	525	519	483	486	545	489	565	542	599	531	637	555	714	732	841	981	1,144	1,295	1,417	1,284	1,206	1,034	1,426	1,541	1,577	1,546	1,383	1,185	1,226	1,197	1,458	1,197	1,228	1,425
Expenses	325	408	406	358	382	426	392	443	459	513	442	523	467	575	581	647	696	765	862	940	883	858	744	1,028	1,085	1,127	1,141	1,095	1,015	1,037	1,014	1,198	1,024	1,045	1,130
EBITDA	87	116	112	125	104	119	97	122	83	86	89	114	88	139	150	194	285	379	433	477	401	348	291	398	456	450	405	287	170	190	184	260	174	183	295
Operating Profit %	21 %	21 %	20 %	24 %	20 %	21 %	18 %	21 %	15 %	13 %	17 %	18 %	15 %	19 %	20 %	23 %	29 %	33 %	33 %	33 %	31 %	29 %	28 %	28 %	30 %	28 %	26 %	21 %	14 %	15 %	15 %	17 %	14 %	15 %	20 %
Depreciation	25	26	27	28	30	30	31	35	38	40	43	44	46	48	48	46	49	51	52	54	59	63	64	66	71	82	84	87	91	93	98	102	106	108	106
Interest	28	25	31	17	19	20	18	23	22	25	24	18	23	26	21	21	15	14	17	22	27	22	23	31	29	40	43	53	39	42	51	51	49	53	58
Profit Before Tax	35	66	54	81	55	70	49	64	23	22	23	53	19	66	82	127	222	314	364	401	316	263	204	302	356	328	278	147	41	54	35	107	19	23	131
Tax	9	18	9	9	16	21	14	19	6	6	5	9	4	9	8	17	50	72	91	104	74	59	49	70	104	95	75	42	14	17	11	32	6	3	38
Net Profit	26	48	45	71	39	49	35	45	17	16	18	43	15	57	74	110	172	242	273	297	242	204	155	232	252	233	203	105	27	37	23	75	13	20	93
EPS in ₹	3.73	5.18	4.50	6.75	3.68	4.61	3.29	4.26	1.56	1.53	1.67	4.07	1.42	1.06	1.38	2.06	3.21	4.53	5.09	5.53	4.50	3.76	2.87	4.29	4.68	4.33	3.78	1.90	0.46	0.69	0.43	1.40	0.23	0.37	1.71

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,894	2,224	2,653	3,017	3,331	3,750	5,751	6,968	7,660	8,387
Fixed Assets	801	1,021	1,230	1,481	1,629	1,726	2,171	2,653	3,409	3,890
Current Assets	865	1,003	1,140	1,248	1,463	1,812	3,075	3,345	3,462	3,835
Capital Work in Progress	110	70	143	163	110	67	362	813	551	423
Investments	0	7	3	3	3	3	3	31	50	124
Other Assets	983	1,126	1,277	1,369	1,589	1,953	3,215	3,472	3,651	3,950
Total Liabilities	1,894	2,224	2,653	3,017	3,331	3,750	5,751	6,968	7,660	8,387
Current Liabilities	805	884	1,121	1,307	1,424	1,692	2,457	2,681	2,432	3,112
Non Current Liabilities	365	483	202	227	349	288	693	928	1,180	1,159
Total Equity	724	857	1,330	1,483	1,558	1,770	2,601	3,359	4,049	4,116
Reserve & Surplus	642	774	1,225	1,371	1,447	1,658	2,490	3,244	3,930	4,003
Share Capital	82	82	106	106	106	107	107	108	108	108

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	24	-27	-10	1	0	-1	47	27	-30	93
Investing Activities	-397	-312	-289	-384	-253	-221	-941	-915	-997	-822
Operating Activities	-65	182	332	343	298	347	733	911	994	666
Financing Activities	486	103	-54	42	-45	-128	255	30	-27	250

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	27.45 %	27.30 %	27.30 %	27.27 %	27.27 %	27.27 %	27.27 %	27.20 %	27.20 %	27.20 %	27.20 %	27.19 %	27.19 %	27.18 %	27.18 %	27.62 %
FIIs	0.00 %	0.04 %	0.04 %	0.02 %	0.02 %	0.02 %	0.00 %	0.02 %	0.02 %	0.00 %	0.00 %	0.00 %	25.97 %	25.67 %	26.08 %	25.56 %
DIIs	2.06 %	2.40 %	2.11 %	2.77 %	3.51 %	4.77 %	8.98 %	9.51 %	9.74 %	10.14 %	10.71 %	10.77 %	11.77 %	13.56 %	13.05 %	12.74 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	34.17 %	34.18 %	32.91 %	32.87 %	31.15 %	28.42 %	27.96 %	28.95 %	28.49 %	28.26 %	26.49 %	25.01 %	23.95 %	22.68 %	22.67 %	22.72 %
Others	36.32 %	36.07 %	37.65 %	37.08 %	38.05 %	39.53 %	35.80 %	34.32 %	34.55 %	34.39 %	35.60 %	37.03 %	11.12 %	10.91 %	11.03 %	11.36 %
No of Share Holders	2,35,836	2,99,257	3,94,053	4,67,419	4,27,465	4,07,186	3,90,695	4,23,931	4,18,615	4,17,977	4,02,640	3,82,880	3,56,830	3,24,059	3,09,063	2,92,214